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New psychoactive substances (NPS) have become a serious public health problem, as 24 
they are continuously changing their structures, modifying their potency and effects on 25 
humans, and therefore novel compounds are unceasingly appearing. One of the major 26 
challenges in forensic analysis, particularly related to the problematic of NPS, is the 27 
development of fast screening methodologies that allow the detection of a wide variety 28 
of compounds in a single analysis. In this study, a novel application of the atmospheric 29 
solids analysis probe (ASAP) using medical swabs has been developed. The swab-ASAP 30 
was coupled to a triple quadrupole mass analyzer working under data-dependent 31 
acquisition mode in order to perform a suspect screening of NPS in different types of 32 
samples as well as in surfaces. The compounds were automatically identified based on 33 
the observed fragmentation spectra using an in-house built MS/MS spectra library. The 34 
developed methodology was applied to the identification of psychoactive substances in 35 
research chemicals and herbal blends. The sensitivity of the method, as well as its 36 
applicability for surface analysis, was also assessed by identifying down to 1 µg of 37 
compound impregnated into a laboratory table. Another remarkable application was the 38 
identification of cathinones and synthetic cannabinoids in the fingers of potential 39 
consumers. Interestingly, our data showed that NPS could be identified in the fingers after 40 
being in contact with the product and even after cleaning their hands by shaking off with 41 
a cloth. The methodology proposed in this paper can be applied for routine analyses of 42 
NPS in different matrix samples without the need to establish a list of target compounds 43 
prior to analysis. 44 
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Introduction  48 
During 2018, 52 new psychoactive substances (NPS) were reported for the first time, 49 
around one compound each week [1, 2]. This trend has been observed during the last 50 
decade, and nowadays more than 700 different NPS are currently being monitored [1, 2]. 51 
The continuous rising of novel compounds increases the need of analytical methodologies 52 
that allow their fast analysis and identification. 53 
Chromatography coupled to mass spectrometry is the most powerful analytical 54 
technique for the analysis of NPS [3] in a wide variety of matrices such as seizures, legal 55 
highs, and biological tissues and fluids [4]. In the last years, the development of ambient 56 
mass ionisation sources that allow the fast and direct analysis of samples, without any 57 
sample treatment, has posed a new promising scenario in forensic analysis [3]. Among 58 
the most commonly used for identification of psychoactive substances it can be 59 
highlighted the direct analysis in real time (DART) [5, 6], desorption electrospray [7], the 60 
recently developed swab touch spray [8], and the atmospheric solids analysis probe 61 
(ASAP), based on an atmospheric chemical ionisation (APCI) modified source, which 62 
have already proved its potential in toxicological analysis [9–11]. The ASAP source has 63 
demonstrated its applicability when coupled to high-resolution mass spectrometry 64 
(HRMS) but also to tandem mass spectrometry (MS/MS) with triple quadrupole [9, 12].  65 
In this work, a rapid and efficient analytical methodology based on a modified ASAP-66 
MS/MS system, has been developed for the suspect screening of a wide variety of NPS, 67 
and has been applied to different cases related to the consumption of these substances. 68 
The glass capillary was replaced by a medical swab in order to allow the determination 69 
of NPS in surfaces, including the fingers of a potential consumer. For suspect screening, 70 
a data-dependent acquisition (DDA) mode was used in the triple quadrupole instrument 71 
to obtain the fragmentation spectra of the compounds. The acquired product ion spectra 72 
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were then automatically searched in an in-house MS/MS spectra database for compound 73 
identification. The applicability of this methodology for tentative identification of 74 
selected NPS was tested in different matrices with emphasis on the sensitivity and 75 
reliability of the identification.  76 
Materials and methods 77 
Reagents and chemicals  78 
Herbal blends, powders and pills were purchased in a local smart-shop and were 79 
previously analyzed by UHPLC-HRMS for compound identification [13]. Research 80 
chemicals had been provided by Energy Control and analyzed by UHPLC-HRMS and 81 
nuclear magnetic resonance for compound identification [14]. HPLC-grade methanol 82 
was purchased from Scharlau (Scharlab, Barcelona, Spain). Medical swabs were 83 
purchased from neoLab (neoLab Migge GmbH, Heidelberg, Germany). 84 
Sample treatment 85 
For direct analysis, a medical swab was placed on the ASAP probe and gently wiped 86 
in the sample or surface. 100 µL of methanol was added to the swab, and introduced into 87 
the ASAP holder for sample analysis. 88 
Instrumentation 89 
Samples were analyzed using a Xevo TQ-S mass spectrometer (Waters Corp, 90 
Manchester, UK) with a triple quadrupole mass analyzer, equipped with an ASAP source 91 
(Waters Corp, Manchester, UK). The corona pin current was 2.0 µA in positive ionization 92 
mode, and the cone voltage 30 V. Source temperature was stablished at 150 ºC, and 93 
desolvation temperature 450 ºC. Nitrogen (Praxair, Valencia, Spain) was used as cone 94 
and desolvation gas at 150 and 800 L/h, respectively. MS/MS was operated in DDA 95 
acquisition mode. Survey MS scan data were acquired from m/z 170 to 450 with a scan 96 
time of 50 ms. For automatic MS/MS, the switch threshold was 5·105 counts/s, acquiring 97 
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data from m/z 60 to 450, with a scan time of 50 ms, using a 25 eV collision induced-98 
dissociation (CID) energy (argon 99.995%; Praxair), an isolation window of 1 Da and an 99 
exclusion time of 10 s for the previously detected precursor ion. Only one m/z value was 100 
selected for MS/MS in each survey MS scan. The total run time was 1.5 min. 101 
Data were acquired using MassLynx data station operation software (v4.1; Waters), 102 
and processed using MassLynx and MS Search (v2.0; NIST, USA) for automatic 103 
compound identification based on DDA MS/MS data. For compound identification, 104 
experimental MS/MS spectrum was directly processed with MassLynx, searching in the 105 
fragmentation spectra database generated in our laboratory. For automatic search, MS 106 
Search software must be installed together with MassLynx. 107 
 108 
Results and discussion 109 
Acquisition parameters optimization and building the spectra library 110 
The ASAP source and the DDA acquisition parameters were carefully optimized for 111 
the use of swabs. Detailed information about the optimization, as well as the construction 112 
of the spectra library, can be found in the electronic supplementary material. 113 
Application to blind samples and detection/identification of NPS in different 114 
surfaces 115 
In order to demonstrate the applicability of the developed methodology for identifying 116 
the active compounds, different experiments were performed to assess selectivity and 117 
sensitivity of the swab-ASAP-MS/MS DDA. 118 
Firstly, the identification of NPS present in blind research chemicals and legal highs 119 
samples was tested. The selected products included herbal blends, pills, crystal and 120 
powder samples, containing NPS of different families. Figure 1 shows the identification 121 
of the synthetic cathinone butylone in a legal high sample named Euforia, purchased in a 122 
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local smartshop through its webpage [13]. The automatic MS/MS function shows the 123 
presence of a certain ion with a high response (Figure 1A). When the MS/MS spectrum 124 
was searched in the database using the MS Search, only one compound presented a match 125 
higher than 800 (minimum value for considering a compound tentatively identified), as 126 
shown in Figure 1B.  127 
The applicability of this approach was supported by the analysis of several research 128 
chemicals containing synthetic cathinones, synthetic cannabinoids, opioids or 129 
tryptamines. For example, the synthetic opioid U-47700 was tentatively identified in a 130 
powder sample by swab-ASAP-MS/MS DDA. In this case, the swab was wiped into the 131 
plastic bag that contained the product. The opioid was tentatively identified with a match 132 
of 859. 133 
The high sensitivity observed when analyzing these products, encouraged us to 134 
perform sensitivity tests using the swab-ASAP. For this purpose, a small amount of 135 
compound was placed onto the laboratory table using a certain volume from a stock 136 
solution at high concentration (e.g., 10 µL from a 1 mg/mL stock solution). In order to 137 
simulate a real situation, the solvent was allowed to evaporate before applying the swab. 138 
In this experiment, 12 µg of the synthetic cannabinoid AMB-FUBINACA and 12 µg of 139 
the tryptamine 5-MeO-MiPT were satisfactorily identified, as it can be observed in 140 
Figure 2A and 2B. Moreover, the methodology allowed the identification of 1 µg of the 141 
synthetic cathinone 3,4-MDPV placed onto the laboratory table as shown in Figure 2C.  142 
To complete the whole set of experiments, the swab-ASAP-MS/MS DDA analysis was 143 
applied to the detection and identification of NPS in fingers of potential consumers who 144 
had touched legal highs with their hands. Experiments consisted on the simulation of 145 
somebody snorting a powder sample or preparing a cigarette with an herbal blend, 146 
cleaning subsequently his hands by shaking off with a cloth. After cleaning their hands 147 
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no traces of powder or herb were observed, being apparently clean. However, the analysis 148 
of the finger surface by swab-ASAP-MS/MS DDA revealed the presence of intense 149 
peaks. Based on the observed fragmentation, it was possible to identify α-PVP after 150 
“snorting” (Figure 3A), as well as the synthetic cannabinoids XLR-11 and UR-144 after 151 
“preparing the cigarette” (Figure 3B). 152 
This approach has proved its potential for the rapid suspect screening of the compounds 153 
present in legal highs and research chemicals, as well as its applicability for detecting 154 
NPS in surfaces, such as the fingers of a potential consumer. Nevertheless, it must be 155 
continuously updated, including more and more fragmentation spectra for NPS, 156 
especially for novel compounds. The major handicap is, nowadays, the lack of on-line 157 
spectral libraries for NPS when using QqQ instruments, similarly to those available for 158 
HRMS [15]. Additionally, details about the use of this approach for the identification of 159 
isomeric compounds are also included in electronic supplementary material. 160 
 161 
Conclusions 162 
The developed methodology, based on swab-ASAP-MS/MS DDA, for the suspect 163 
screening of NPS in seizures and different surfaces in contact with a variety of products 164 
has demonstrated its applicability with high sensitivity and selectivity. It has allowed the 165 
identification of different families of NPS in several legal highs and research chemicals 166 
tested. The identification was fast, without the need of any sample treatment, and it was 167 
automatically performed by searching the acquired fragmentation spectra in an in-house 168 
built spectra database. The use of medical swabs was also tested for the analysis of 169 
different surfaces that were in contact with NPS, supporting the suitability of this 170 
approach for detecting low amounts of these compounds in a laboratory table, as well as 171 
in the fingers of a person who used legal highs. The methodology proposed in this work 172 
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should be continuously updated by including the fragmentation spectra of novel NPS. 173 
This would allow to build a wide spectra database that would notably facilitate the routine 174 
monitoring of the ever-changing NPS market. Additionally, future work will include the 175 
possibility of the use of swab-ASAP-MS/MS for quantification purposes, using 176 
calibration curves or isotope pattern deconvolution quantification for those compounds 177 
with isotopically-labelled standard available. 178 
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Figure 1. Identification of the synthetic cathinone butylone in a legal high sample. A 259 
Automatic MS/MS function generated during DDA analysis. B Compound identification 260 
using MS Search v2.0 and the in-house built database. 261 




Figure 2. Analysis of NPS placed in the laboratory table. A 12 µg of the synthetic 264 
cannabinoid AMB-FUBINACA. B 12 µg of the tryptamine 5-MeO-MiPT. C 1 µg of the 265 
cathinone MDPV. 266 




Figure 3. Analysis of NPS in the finger of a volunteer who had touched different products 269 
and had cleaned his hands by shaking off with a cloth. A Identification of the cathinone 270 
α-PVP after being in contact with a powder sample. B Identification of the cannabinoids 271 
UR-144 and XLR-11 (halogenated compound) after being in contact with an herbal blend 272 
sample. 273 
 274 
